Led by Eco Polymer and co-developed with Shandong Weigao Group, the Chinese PLA General Hospital, Soochow University and other institutions, the project entitled Research, Development, Production and Application of Polymethyl Methacrylate (PMP) Hollow Fiber Membranes for Extracorporeal Membrane Oxygenation has been successfully selected into the first batch of the national program. This milestone marks a new stage in the development of China's medical biomaterials sector!

On July 19th, the Ministry of Industry and Information Technology officially announced the evaluation results of the 2023 National Development Plan for Medical Biomaterials. Eco Polymer, together with its partners including Shandong Weigao Group, the Chinese PLA General Hospital and Soochow University, was successfully selected for the first batch of projects, set to spearhead revolutionary changes in the field of medical biomaterials.

This project aims to lead the advancement of China's medical biomaterials. As a life-saving technology for patients with severe respiratory or cardiac failure, Extracorporeal Membrane Oxygenation (ECMO) relies heavily on specialized materials, especially membrane materials for oxygenation. Leading this groundbreaking project will drive innovation in China's domestic ECMO technology sector. This major breakthrough signals a new phase for Eco Polymer and its partners, who are striving to break the import monopoly of core ECMO consumables and fill the gap in domestic production.

Going forward, as a pioneer in the development of medical biomaterials, Eco Polymer will collaborate with all participating institutions to continue challenging the import monopoly of core ECMO consumables. By overcoming technical barriers and embracing cutting-edge innovation, the team aims to reduce reliance on imports, establish a domestic supply chain, and realize the localization of this critical medical technology.

This major breakthrough aligns with China's vision of becoming a global leader in innovation and sets a new benchmark for the domestic medical industry. It reflects Eco Polymer's unwavering commitment to innovation, ensuring this life-saving technology is accessible to patients in need.

On this exciting journey, the company invites industry experts, researchers and stakeholders to join in the collaboration, foster synergy, and work together to build a revolutionary future for medical biomaterials. This achievement represents not only technological progress, but also demonstrates Eco Polymer's dedication to advancing healthcare development.

Eco Polymer's successful selection into the National Development Plan for Medical Biomaterials heralds the arrival of a new era for high-end medical solutions of "Made in China". Eco Polymer will continue to forge ahead, focusing on the development of biomedical materials for pharmaceutical microfiltration, virus removal membranes and hollow fiber ultrafiltration membranes, leaping from "Made in China" to "Created in China". With a commitment to excellence, Eco Polymer and its partners will lead the future of biomedical innovation.